Skip to content
glp1.howSign in

Mental & Social Health

Generalized anxiety disorder (GAD)

Generalized anxiety disorder is a persistent pattern of excessive, hard-to-control worry across many areas of life, lasting months and interfering with daily functioning.

By the glp1.how editorial teamReviewed

Generalized anxiety disorder (GAD) is a diagnosable condition, distinct from ordinary stress: worry that is excessive, spreads across many areas of life, is hard to switch off, and persists for months. It often comes with physical symptoms — restlessness, muscle tension, fatigue, trouble concentrating, irritability, and disrupted sleep. GAD is common and treatable, usually with psychotherapy (particularly cognitive behavioral therapy), medication such as SSRIs, or both.

It matters on a GLP-1 because anxiety can move in either direction during treatment. Steadier blood sugar, quieter food noise, and weight change ease anxiety for some people, while a minority notice new or worsening anxiety, and drug-safety databases show a small reporting signal. A GLP-1 is not a treatment for anxiety. If worry is persistent and getting in the way of daily life, that's worth raising with a prescriber or mental-health professional — see the guides on GLP-1 medications and anxiety and getting mental health support on a GLP-1. Source: NIMH (external link).

anxietymental-healthglossary

Revision history

Updated 1 time since Sep 2, 2026 · show changes
  1. v2

    Body revised

  2. v1

    Change tracking began

Related guides

  • GLP-1 medications and anxiety: what the evidence shows, and what to watch · Do GLP-1 medications cause anxiety? Large trial data say no overall increase: a 2026 meta-analysis of 86 randomized trials found no link, and the FDA's January 2026 review of 91 trials found no rise in anxiety or other psychiatric events. People still vary. Most stay stable, some feel calmer, and a minority develop new or worse anxiety. It is not a treatment for anxiety. This guide covers the evidence, what to monitor, and when to get help.
  • GLP-1 medications and depression: what the evidence shows, and what to watch · Do GLP-1 medications cause depression? The best evidence says no increase in the randomized trials, and in January 2026 the FDA asked for the suicidal-ideation warning to come off the Saxenda, Wegovy and Zepbound labels. Some real-world studies still find a small depression signal, depending on what the drug is compared with, and the months after stopping deserve attention. The drug isn't a depression treatment either. This guide covers the evidence on both sides, what to watch, and when to get help.
  • GLP-1 medications and ADHD: what to know if you have both · ADHD and obesity often go together, so a meaningful number of people on a GLP-1 also have ADHD, and some take a stimulant. There are no trials of GLP-1s as an ADHD treatment, and they shouldn't be used as one. If you have both, three practical things matter: combining two appetite suppressants safely, the overlap between ADHD and eating, and the adherence hurdle a weekly injection poses when you have ADHD.
  • Getting mental health support while on a GLP-1: finding a therapist and the challenges to name · Losing weight on a GLP-1 changes more than your body. Appetite, self-image, coping habits, and how others treat you can all shift, sometimes faster than your mind catches up. This practical guide covers the mental-health challenges people commonly face on these medications, the kinds of professionals who can help, how to find and afford one, and the crisis resources to keep close.
  • GLP-1s and a history of disordered eating: what the evidence says about safety · If you have a history of an eating disorder, or are living with one, a medication that suppresses appetite raises real questions. This guide covers what the early, mixed evidence shows about GLP-1 safety, why an active restrictive disorder is a different situation, and why the decision belongs with a treatment team that includes a mental-health professional.
  • Body-image lag after weight loss vs. body dysmorphia: how to tell the difference · After losing weight on a GLP-1, many people still 'feel' like their old body because the mind lags behind the mirror. That lag, nicknamed "phantom fat" or "ghost fat," is common and usually eases. Body dysmorphic disorder is different: a persistent, distorted preoccupation with appearance that needs professional care. This guide explains how to tell them apart, what helps your body image catch up, and where to get help.

Related terms

  • Cognitive behavioral therapy · A structured, time-limited form of talk therapy (CBT) that works on the links between thoughts, feelings, and behaviors, with strong evidence for anxiety, depression, insomnia, and binge eating.
  • Food noise · A colloquial term for persistent, intrusive thoughts about food — commonly reported to diminish significantly on GLP-1 medications.
  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.

Was this helpful?

Improve this page